Anti-tumor effect of polysaccharides isolated from Taraxacum mongolicum Hand-Mazz on MCF-7 human breast cancer cells
Abstract
Purpose: To optimize the extraction conditions for the ultrasound-assisted extraction of polysaccharides from T. mongolicum (PTM) and investigate their anti-tumor effect on human breast cancer MCF-7 cells.
Methods: To optimize the extraction conditions of PTM, response surface methodology (RSM) was performed. The effects of extraction temperature, liquid-solid ratio and extraction time on the yield of PTM were investigated using a Box-Behnken design (BBD). The in vitro anti-tumor effect of PTM on MCF-7 cells was investigated by methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, while the mechanism of PTM-induced apoptosis was assessed by evaluating the expressions of p53, Bax and Bcl-2 proteins using western blot analysis. Furthermore, the in vivo anti-tumor effect of PTM on MCF-7 cells was studied in mice.
Results: The optimal conditions for the extraction of PTM were as follows: extraction temperature, 58.2°C; liquid-solid ratio, 15 mL/g; and extraction time, 44.12 min. Under these optimal conditions, the yield of PTM was 4.84 ± 0.13 %. PTM showed significant anti-tumor effect on MCF-7 cells in vitro. The expressions of pro-apoptotic proteins, p53 and Bax, were significantly upregulated (p < 0.05), while the expression of anti-apoptotic protein, Bcl-2, was significantly down-regulated (p < 0.05) after treatment with PTM. PTM also showed significant inhibitory effect (p < 0.05) on MCF-7 cells in vivo in a dosedependent manner.
Conclusion: RSM is effective in optimizing the extraction conditions of PTM by ultrasonic extraction. PTM possesses significant anti-tumor effect on MCF-7 human breast cancer cells, both in vitro and in vivo.
Keywords: Polysaccharides, Taraxacum mongolicum, Human breast cancer, MCF-7 cells, Apoptosis, Box–Behnken design, Response surface methodology
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
